147 related articles for article (PubMed ID: 32163859)
1. Addressing the barriers to optimal management of febrile neutropenia in children with cancer.
Anderson K; Bradford N; Edwards R; Nicholson J; Lockwood L; Clark J
Eur J Oncol Nurs; 2020 Apr; 45():101719. PubMed ID: 32163859
[TBL] [Abstract][Full Text] [Related]
2. Through Their Eyes: Parental Perceptions on Hospital Admissions for Febrile Neutropenia in Children With Cancer.
Anderson KJ; Bradford NK; Clark JE
J Pediatr Oncol Nurs; 2018; 35(5):342-352. PubMed ID: 29871527
[TBL] [Abstract][Full Text] [Related]
3. Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers.
Cohen C; King A; Lin CP; Friedman GK; Monroe K; Kutny M
Pediatr Emerg Care; 2016 Nov; 32(11):739-745. PubMed ID: 25822237
[TBL] [Abstract][Full Text] [Related]
4. Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles.
Geerlinks AV; Digout C; Bernstein M; Chan A; MacPhee S; Pambrun C; Gallant G; Wyatt L; Fernandez CV; Price VE
Pediatr Emerg Care; 2020 Nov; 36(11):509-514. PubMed ID: 33125202
[TBL] [Abstract][Full Text] [Related]
5. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
[TBL] [Abstract][Full Text] [Related]
6. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.
Daniels LM; Durani U; Barreto JN; O'Horo JC; Siddiqui MA; Park JG; Tosh PK
Support Care Cancer; 2019 Nov; 27(11):4171-4177. PubMed ID: 30805726
[TBL] [Abstract][Full Text] [Related]
7. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
[TBL] [Abstract][Full Text] [Related]
9. Principles, practices and knowledge of clinicians when assessing febrile children: a qualitative study in Kenya.
Hooft AM; Ripp K; Ndenga B; Mutuku F; Vu D; Baltzell K; Masese LN; Vulule J; Mukoko D; LaBeaud AD
Malar J; 2017 Sep; 16(1):381. PubMed ID: 28931399
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.
Kapil P; MacMillan M; Carvalho M; Lymburner P; Fung R; Almeida B; Van Dorn L; Enright K
J Oncol Pract; 2016 Sep; 12(9):e858-63. PubMed ID: 27486160
[TBL] [Abstract][Full Text] [Related]
11. Time to antibiotics and outcomes in cancer patients with febrile neutropenia.
Perron T; Emara M; Ahmed S
BMC Health Serv Res; 2014 Apr; 14():162. PubMed ID: 24716604
[TBL] [Abstract][Full Text] [Related]
12. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
13. Parental perspectives on inpatient versus outpatient management of pediatric febrile neutropenia.
Diorio C; Martino J; Boydell KM; Ethier MC; Mayo C; Wing R; Teuffel O; Sung L; Tomlinson D
J Pediatr Oncol Nurs; 2011; 28(6):355-62. PubMed ID: 22194148
[TBL] [Abstract][Full Text] [Related]
14. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
[TBL] [Abstract][Full Text] [Related]
16. Febrile neutropenia: median door-to-needle time - results of an initial audit.
Ali N; Baqir M; Hamid A; Khurshid M
Hematology; 2015 Jan; 20(1):26-30. PubMed ID: 24724830
[TBL] [Abstract][Full Text] [Related]
17. Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients.
Sano H; Kobayashi R; Suzuki D; Kishimoto K; Hori D; Matsushima S; Yoshida M; Sarashina T; Toriumi N; Kobayashi K
Int J Hematol; 2018 Nov; 108(5):543-549. PubMed ID: 30039441
[TBL] [Abstract][Full Text] [Related]
18. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
19. Febrile neutropenia: outline of management.
Oberoi S; Suthar R; Bansal D; Marwaha RK
Indian J Pediatr; 2013 Feb; 80(2):138-43. PubMed ID: 23180404
[TBL] [Abstract][Full Text] [Related]
20. Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement Intervention.
Yoshida H; Leger KJ; Xu M; Migita RT; Rutledge JC; Pollard JA; Kroon L; Mazor SS; Moon A; Rutman LE
Pediatr Emerg Care; 2018 Jan; 34(1):47-52. PubMed ID: 29293201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
